Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-21-005823

Chief Executive Officer acquired 5,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-16 Grant or award : show line 1 in the form +5,000 $1.28 $6,400 905,298 D
Loading xslF345X03/ownership.xml…